• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10 Orthopedic Device Firms
    • Buyers' Guide
    • Events
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10 Orthopedic Device Firms
  • Buyers' Guide
  • Events
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    Top Features
    From Nitinol to Nanotubes: A Materials Science Roundtable

    In Good Repair: Trauma Technologies Under Review

    Anxious Undertones: A Review of 2019

    Automated Analysis Advantages for Part Validation

    Tried and True Metalworking
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    Orthofix Appoints New Spine Business Leader

    Viant to Halt EtO Sterilization at Michigan Plant by End of Year

    Synaptive Medical's Modus V Expands Into Spine Market

    3D-Printed Graftless Bone Transplants Go to Clinical Trials

    CrossRoads Extremity Systems Acquires Implant Systems from Surgical Frontiers
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    3D-Printed Graftless Bone Transplants Go to Clinical Trials

    CrossRoads Extremity Systems Acquires Implant Systems from Surgical Frontiers

    Micro Spine Implant Could Restore Standing and Walking

    RTI Surgical Appoints New Division Leaders

    From Nitinol to Nanotubes: A Materials Science Roundtable
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    Molybdenum-Rhenium Biomaterial: Something ‘MoRe’?

    New Exoskeleton Shoulders Rehab Burden for Stroke Patients

    Repairing Knee Cartilage Defects with the Patient's Own Cells

    Compamed 2019 Preview Report

    Straightening Out a Spinal Device’s De Novo Pathway
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    Donatelle

    Orchid Orthopedic Solutions

    NN Life Sciences

    Hammill Medical

    Nelson Laboratories LLC
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10 Orthopedic Device Firms
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Columns

    U.S. May Offer a Safe Harbor from the Impending MDR Storm

    There are factors that make for a more inviting environment for the medical device industry in the United States.

    U.S. May Offer a Safe Harbor from the Impending MDR Storm
    Related CONTENT
    • Why Big Companies With Internal Labs Should Outsource Testing
    • Pain Control Technology Embraces the Challenge to Reduce or Eliminate Opioids
    • ODT Forum Program Notebook
    • SI-BONE's iFuse Bedrock Spinopelvic Fixation Technology Gains Additional FDA Nod
    • Dominating the Competition with Digitization
    Dawn A. Lissy, President & Founder, Empirical09.17.19
    My last column was a bit of a downer. I wrote about all the concerns I have with the changes coming from the European Medical Device Regulation (MDR) set to take effect in May 2020. (Spoiler alert—there were many.) While I still hold the opinion that the effects of MDR will leave our industry FUBAR across the pond, I’m now focusing on the bright side here in the United States, where the forecast for medical device developers is considerably brighter.

    Political winds have shifted. In 2013, the medical device tax sent some major players running to Europe to avoid the 2.3 percent up-front revenue tax. That tax has been repeatedly suspended by Congress, and  the current bill to repeal it has rare bipartisan support.

    There are other factors that make for a more inviting environment for the medical device industry in the United States. The U.S. Food and Drug Administration (FDA) seems to recognize America is in line to receive the overflow from companies that won’t receive CE marks under MDR.

    My colleague Meredith May, vice president of Empirical Consulting, is my go-to source on all things regulatory. Based on what we’re seeing in the industry, we predict a significant shift in how devices are developing on the global stage. Clients that would typically work to obtain a CE mark before a 510(k) are now taking the opposite approach.

    “MDR is disrupting the EU market and much of the world,” she said. “Pre-MDR, it was faster to get a device into the EU market because the review process was controlled by [the developer]. All you had to prove was safety. In the U.S., we have to prove safety, efficacy, and substantial equivalent.

    “It used to be really easy—you might have to have clinical trials in the U.S., but it was almost guaranteed you didn’t need it in the EU. Now it’s more likely you’ll need clinical investigation in Europe than in the U.S.”

    That means higher costs and more time, perhaps two to three times longer to meet MDR requirements than a 510(k).

    “Your Class II device likely will not require clinical trials and investigation, which can cost anywhere from about $300,000 to about $2 million and take an extra nine months to five years depending on your end points,” May said. “No startups that I know of could manage that. That’s a huge financial and resource burden for startups.”

    That’s assuming you can find a notified body certified under MDR. Currently, only two of 58 European notified bodies are certified, and they’ve stopped taking new applications for CE marks due to the backlog of companies trying to renew their CE marks before May 2020. But FDA is up to date and moving forward with new 510(k)s. They’re also consistently releasing guidance documents, something MDR has yet to begin.

    “Even if you are trying to stick it out in Europe, you won’t know how to do that,” May said.

    Another FDA effort to speed the path to market: the Payor Communication Task Force. The program to facilitate early conversations with insurance companies and others is not a new resource—it launched in 2014. But it’s now generating more momentum and buy-in from developers wanting to be better positioned for having a device not just cleared for use in the patient, but also blessed for coverage by insurance companies.

    It seems like a no-brainer: If the FDA says a device is safe, it should be a viable treatment option. But the bar is different. FDA wants proof that a device is safe and effective. Payors want to know a device improves health outcomes and is reasonable and necessary for their beneficiaries. These different payor standards may require different data from what the FDA reviewed, which can result in limited or no coverage after a company or innovator has spent substantial time and money to earn FDA approval or clearance.

    To further complicate the issue, a device may earn national and/or local coverage, meaning your hometown hospital may not cover the same devices as the Mayo Clinic. Again, this comes back to different data sets and expectations that can add time and cost to the development timeline if they’re not addressed early on.

    The Payor Communication Task Force facilitates conversations about data development, and the innovator may choose to incorporate payor suggestions into a device’s development plan. Rather than adding time and cost after marketing approval is obtained from FDA, device developers who work with the task force get suggested parameters and recommendations from payors to better position their device for reimbursement once it’s cleared or approved by FDA.

    It’s yet another example of how FDA is working to support patient access to innovative medical devices and for device developers, which we’re just not seeing in Europe right now.

    “If you take all of those things and look at them, the FDA is trying to have a more transparent and consistent process, whereas the MDR is creating a more muddled and confusing process in addition to adding time and cost,” May said. “In a sense, the FDA is trying to make it easier, not harder. The EU is trying to make it harder, not easier.”

    I remain hopeful the EU will come up with solutions for the current backlog and better processes for the future. Until then, we’re working to keep up with the market shift and do our part to support our industry. I trust that bright minds and commitment to best patient outcomes will eventually prevail, but hope that happens before May 2020. 


    Dawn Lissy is a biomedical engineer, entrepreneur, and innovator. Since 1998, the Empirical family of companies (Empirical Testing Corp., Empirical Consulting LLC, and Empirical Machine LLC) has operated under Lissy’s direction. Empirical offers the full range of regulatory and quality systems consulting, testing, small batch and prototype manufacturing, and validations services to bring a medical device to market. Empirical is very active within standards development organization ASTM International and has one of the widest scopes of test methods of any accredited independent lab in the United States. Because Lissy was a member of the U.S. Food and Drug Administration’s Entrepreneur-in-Residence program, she has first-hand, in-depth knowledge of the regulatory landscape. Lissy holds an inventor patent for the Stackable Cage System for corpectomy and vertebrectomy. Her M.S. in biomedical engineering is from The University of Akron, Ohio. 
    Related Searches
    • clearance
    • developer
    • device tax
    • running
    Suggested For You
    Making the Grade: A Testing and Analysis Roundtable Making the Grade: A Testing and Analysis Roundtable
    ApiFix Receives FDA Approval for MID-C System ApiFix Receives FDA Approval for MID-C System
    Mayday: How the Upcoming MDR Implementation Forecasts Disaster for Our Industry Mayday: How the Upcoming MDR Implementation Forecasts Disaster for Our Industry
    FDA OKs OrthoPediatrics FDA OKs OrthoPediatrics' Next-Gen Cannulated Screw System
    FDA OKs Erchonia FDA OKs Erchonia's FX 635 Laser for Chronic Musculoskeletal Pain Relief
    PAVmed Announces First Human CarpX Procedures PAVmed Announces First Human CarpX Procedures
    FDA OKs First Test to Help Detect Prosthetic Joint Infections FDA OKs First Test to Help Detect Prosthetic Joint Infections
    What’s ‘In’ for Manufacturing? (Hint: It’s Not Neon) What’s ‘In’ for Manufacturing? (Hint: It’s Not Neon)
    Developing Market Access Strategies Developing Market Access Strategies
    Dominating the Competition with Digitization Dominating the Competition with Digitization
    SI-BONE SI-BONE's iFuse Bedrock Spinopelvic Fixation Technology Gains Additional FDA Nod
    ODT Forum Program Notebook ODT Forum Program Notebook
    Pain Control Technology Embraces the Challenge to Reduce or Eliminate Opioids Pain Control Technology Embraces the Challenge to Reduce or Eliminate Opioids
    Why Big Companies With Internal Labs Should Outsource Testing Why Big Companies With Internal Labs Should Outsource Testing

    Related Columns

    • Extremities
      Toe Fusion Alternatives Gaining a Firm Market Foothold

      Toe Fusion Alternatives Gaining a Firm Market Foothold

      Dr. Carl Hasselman, co-designer of the Arthrosurface ToeMotion Arthroplasty System, speaks about non-fusion alternatives for MTPJ osteoarthritis.
      Michael Barbella, Managing Editor 12.02.19

    • The Cluster Effect in Orthopedics: Is It Sustainable?

      The Cluster Effect in Orthopedics: Is It Sustainable?

      For a long time, we all assumed Minnesota dominated the medical device industry worldwide, but is this true for the orthopedic surgical tools industry?
      Maria Shepherd, President and Founder, Medi-Vantage 12.02.19

    • ‘If You’re Reading This, You Need to Be at This Meeting’

      ‘If You’re Reading This, You Need to Be at This Meeting’

      The AAOS/FDA/Industry Townhall is taking place March 24, 2020, at the AAOS annual meeting in Orlando.
      Dawn A. Lissy, President & Founder, Empirical 12.02.19


    • Turning the New EU MDR Into a Competitive Advantage

      Turning the New EU MDR Into a Competitive Advantage

      This column examines three new elements of the EU MDR that medical device manufacturers can leverage.
      Dan Goldstein, Associate Director, Quality Assurance, MCRA LLC 12.02.19

    • Design | Large Joint | Spine/Neurology
      Five Reasons for the Small World of Orthopedic Product Development

      Five Reasons for the Small World of Orthopedic Product Development

      Why do product development people tend to stay within the orthopedic and spine industry and not cross over into other medtech sectors?
      Victoria Trafka, BSME, MSME, President and Lead Engineer, Engineering & Quality Solutions Inc. 12.02.19

    • Impeachment, Executive Orders, and Must-Pass Congressional Legislation: A Fall Update

      Impeachment, Executive Orders, and Must-Pass Congressional Legislation: A Fall Update

      The final quarter of 2019 has begun, which means Congress and the Trump Administration are hard at work finalizing healthcare initiatives before year's end.
      Jeffrey J. Kimbell, David C. Rudloff, and Caroline P. Tucker, Jeffrey J. Kimbell & Associates Inc. 12.02.19


    • Spine/Neurology
      Pediatric Orthopedics Taken Off the Back Burner

      Pediatric Orthopedics Taken Off the Back Burner

      There are several different types of scoliosis, a condition that causes a sideways spinal curve, that affect children and adolescents.
      Sam Brusco, Associate Editor 09.17.19

    • What Are Orthopedic Surgeon Salary and Employment Statistics?

      What Are Orthopedic Surgeon Salary and Employment Statistics?

      The percent of employed physicians is greater than self-employed physicians.
      Maria Shepherd, President and Founder, Medi-Vantage 09.17.19

    • How Identifying Gaps in Clinical Data Can Ease the Transition to New Regulations

      How Identifying Gaps in Clinical Data Can Ease the Transition to New Regulations

      As of 2017, the European medical device market was estimated  at $126 billion, the second largest worldwide, comprising 27 percent of the global market. The European market trails only the United States, which accounts for roughly 43 percent of…
      Mike Goodson, Associate Director, Regulatory Affairs, MCRA LLC 09.17.19


    • Software & Quality
      Benefiting from Paperless Production Records: A Case Study

      Benefiting from Paperless Production Records: A Case Study

      EpiBone discovered how eliminating paper with digital production records can help ensure data integrity, reduce errors, and increase efficiency.
      Terrance Holbrook, Director of Product, MasterControl 09.17.19

    • Connecting the Dots in Medical Device Outsourcing

      Connecting the Dots in Medical Device Outsourcing

      San Francisco is globally renowned for many things: The Golden Gate Bridge (its color, international orange, was actually a primer used to protect the steel during transit), Ghirardelli chocolate, the TransAmerica pyramid building, and the “Pai…
      ODT Staff 08.14.19

    • What Keeps Hospital CEOs Awake at Night and How Can Medtech Help?

      What Keeps Hospital CEOs Awake at Night and How Can Medtech Help?

      With the continued surge of mergers and acquisitions, vertical integrations, and no clear U.S. policy or reform direction for our $3.6 trillion annual healthcare spend,1 the healthcare ecosystem remains in a phase of dramatic disruption. What Is K…
      Maria Shepherd, President and Founder, Medi-Vantage 08.14.19

    • Mayday: How the Upcoming MDR Implementation Forecasts Disaster for Our Industry

      Mayday: How the Upcoming MDR Implementation Forecasts Disaster for Our Industry

      I’m generally an optimistic person. My outgoing voicemail greeting encourages every caller to “keep smiling!” My wardrobe is about 40 percent “Life is Good” apparel and I keep a daily gratitude journal. Despite this s…
      Dawn A. Lissy, President & Founder, Empirical 08.14.19

    • Successful Strategies for Health Plan Medical Policy Outreach

      Successful Strategies for Health Plan Medical Policy Outreach

      Getting approval from the FDA can be a significant achievement for a company but a bigger challenge awaits for novel technologies: health payor acceptance and coverage. Adopting a novel technology does not occur easily due to complex commercial insur…
      Chelsey Jaworski and Anabel Tapia, MCRA 08.14.19

    • Design
      Why and How Good Design Matters to the Bottom Line

      Why and How Good Design Matters to the Bottom Line

      There should be no confusion: good design pays dividends. Literally. Many highly successful medical products that substantively improve the delivery of healthcare also significantly increase market share and revenue. But just what is the elusive good…
      Bryce G. Rutter, Ph.D., Founder and CEO, Metaphase Design Group Inc. 08.14.19


    Breaking News
    • Orthofix Appoints New Spine Business Leader
    • Viant to Halt EtO Sterilization at Michigan Plant by End of Year
    • Synaptive Medical's Modus V Expands Into Spine Market
    • 3D-Printed Graftless Bone Transplants Go to Clinical Trials
    • CrossRoads Extremity Systems Acquires Implant Systems from Surgical Frontiers
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • From Nitinol to Nanotubes: A Materials Science Roundtable
    • In Good Repair: Trauma Technologies Under Review
    • Anxious Undertones: A Review of 2019
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    International Scientific Society Calls for Omega-3 Blood Testing in Future Research
    Pharmactive Affron Saffron May Help Relieve Depression Symptoms
    Warmer Temperatures Could Lead to Concerning Levels of Arsenic in Rice
    Coatings World

    Latest Breaking News From Coatings World

    Cristo Rey High School Educator Named 2019 Axalta All-Pro Teacher of the Year
    Michelman Makes United Way of Greater Cincinnati’s List of Top 25 Corporate Campaigns
    BCF: Coatings Industry Reports Record Improvement in Waste, Recycling, Accident Rates
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs Roche's Nasal Swab MRSA Test
    Philips & Paige to Deliver Clinical-Grade AI Applications to Pathology Labs
    Eye Test for Parkinson's Gains Breakthrough Designation
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Almac Awarded $1M BMGF Grant
    Vivera Pharma, Parexel Ink Clinical Services Agreement
    MedPharm Triples Capacity at RTP Site
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    WWP Wins Three NJPEC Awards
    Cat-Themed Beauty Collection to Launch in Japan
    Pantone Names Classic Blue the 2020 Color of the Year
    Happi

    Latest Breaking News From Happi

    Lip Lab Opening in Brooklyn
    Raining Rose Expands Exec Team
    Scott’s Sells Personal Care Production Site
    Ink World

    Latest Breaking News From Ink World

    ePac Flexible Packaging Expands into Asia Pacific Market
    Haney, HP Developing Sustainable Fashion Packaging for Heron Preston
    Addipel Moves to New HQ, Expands Production Facility
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    HP teams with Haney for sustainable packaging
    Tags & Labels Printing adds Heidelberg’s Versafire EP
    Austrian converter installs first Nilpeter press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Thrace to Relocate U.S. Capacity
    FiltXPO Speaker Line-Up Announced
    Nölken Incorporates Sustainable Wipes Packaging
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthofix Appoints New Spine Business Leader
    Viant to Halt EtO Sterilization at Michigan Plant by End of Year
    Synaptive Medical's Modus V Expands Into Spine Market
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    IDTechEx Show! Announces Graphene Award Winner
    OE-A Continues to Bring Future of Printed Electronics to CES 2020
    Avancis, Smit Thermal, HZB, CNRS, Solliace Team for Higher Efficiencies in CIGS

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.